Condition
Breast Ductal Carcinoma In Situ
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 24 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
24 shownA Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast DuctsNCT07339306 · 2026-01-01
RECRUITINGLow Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk ReductionNCT06195306 · 2025-07-28
RECRUITINGAcolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerNCT05941520 · 2024-10-10
RECRUITINGFinding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE TrialNCT06184750 · 2024-09-27
RECRUITINGIdentifying and Caring for Individuals With Inherited Cancer SyndromeNCT04494945 · 2020-03-09
RECRUITINGA Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In SituNCT04144023 · 2019-06-27
RECRUITINGImpact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast SurgeryNCT04169542 · 2019-05-21
RECRUITINGTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19
SUSPENDEDFezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialNCT06617455 · 2024-10-31
TERMINATEDHigh Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast CancerNCT06538389 · 2024-08-26
SUSPENDEDMetformin and Nightly Fasting in Women With Early Breast CancerNCT05023967 · 2023-04-04
ACTIVE_NOT_RECRUITINGVolumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID StudyNCT05545150 · 2022-11-28
COMPLETEDComparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast CancerNCT05340673 · 2022-09-09
ACTIVE_NOT_RECRUITINGAn Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsNCT05012176 · 2021-11-01
COMPLETEDEMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast CancerNCT05086705 · 2020-10-07
COMPLETEDAbemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerNCT03979508 · 2020-01-10
TERMINATEDEffect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerNCT04022772 · 2019-07-31
COMPLETEDPhase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryNCT03317405 · 2018-10-31
ACTIVE_NOT_RECRUITINGBexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerNCT03323658 · 2018-06-15
COMPLETEDRetinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast CancerNCT02876640 · 2018-03-16
TERMINATEDBreast Cancer WEight Loss Study (BWEL Study)NCT02750826 · 2016-09-16
ACTIVE_NOT_RECRUITINGNelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast CancerNCT02636582 · 2016-06-14
COMPLETEDTamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28
ACTIVE_NOT_RECRUITINGRadiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10
COMPLETEDCommon interventions
Questionnaire AdministrationOTHER13Biospecimen CollectionPROCEDURE10Quality-of-Life AssessmentOTHER5TamoxifenDRUG4Laboratory Biomarker AnalysisOTHER3MammographyPROCEDURE3Therapeutic Conventional SurgeryPROCEDURE3AnastrozoleDRUG2Biopsy ProcedurePROCEDURE2ExemestaneDRUG2LetrozoleDRUG2Placebo AdministrationDRUG2Random Periareolar Fine-Needle AspirationPROCEDURE2AbemaciclibDRUG1Acolbifene HydrochlorideDRUG1Agent Affecting Integumentary SystemDRUG1Behavioral InterventionBEHAVIORAL1Best PracticeOTHER1BexaroteneDRUG1BRC-001DRUG1conventional localization marker needleDEVICE1Dual X-ray AbsorptiometryBIOLOGICAL1Echocardiography TestPROCEDURE1EMBr WaveDEVICE1Endoxifen HydrochlorideDRUG1
Leading sponsors
National Cancer Institute (NCI)
9
M.D. Anderson Cancer Center
3
Alliance for Clinical Trials in Oncology
2
City of Hope Medical Center
2
Mayo Clinic
2
Ohio State University Comprehensive Cancer Center
2
Northwestern University
1
OHSU Knight Cancer Institute
1
The Fourth Affiliated Hospital of China Medical University
1
University of Michigan Rogel Cancer Center
1
Trial status mix
COMPLETED7
RECRUITING7
ACTIVE_NOT_RECRUITING5
TERMINATED3
SUSPENDED2
Phase mix
PHASE29
NA5
PHASE15
PHASE34
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.